Don’t Miss These Upcoming ASE Live Webinars!

 

Human Deep Hypothermic Cooling versus Animal Hibernation: Echocardiographic Insights

October 27, 2022 | 5:00 – 6:00 PM ET

The cardiovascular changes that occur during deep anesthesia in people may be mirrored in animals that hibernate: hypothermia, bradycardia, etc. In one context, these changes occur in a medical environment whereas in the other, they are a part of normal life. This session proposes that knowledge can be gained by pairing the perspectives of a human cardiothoracic anesthesiologist, Dr. Burkhard Mackensen, and a veterinary cardiologist with expertise in hibernating bears, Dr. Lynne Nelson. This is the first webinar offered by the ASE Veterinary Specialty Interest Group.

Moderator

  • Etienne Côté DVM, DACVIM (Cardiology, SAIM), FACC, FCAHS

Speakers

  • G. Burkhard Mackensen, MD, PhD, FASE
  • O. Lynne Nelson, DVM, MS, DACVIM (Cardiology, SAIM)

Learning Objectives

  • Better understand selected cardiovascular aspects of deep hypothermic anesthesia in humans, including echocardiographic aspects
  • Better understand selected cardiovascular aspects of hibernation in large mammals, including echocardiographic aspects
  • Gain additional insights into human cardiovascular physiology through understanding the changes that occur during hibernation, and into veterinary cardiovascular physiology through understanding the changes that occur during human deep hypothermic anesthesia

Earn 1 AMA PRA Category 1 Credit™ (CME/MOC) (pending approval).

This activity is FREE for ASE members and nonmembers. Remember to log in to the Member Portal.

 

Knowledge is Power: Considerations Before Signing an Employment Contract

November 07, 2022 | 7:00 – 8:00 PM ET

This webinar is a talk by employment attorney Renu Thamman on the key items to consider and negotiate before signing an agreement. With the increase in corporate medicine, doctors can no longer blindly sign these agreements that can have a serious impact on their future.

Moderator

  • Ritu Thamman, MD, FASE, FACC

Speaker

  • Renu Thamman

Learning Objectives

  • Learn the key items to consider before signing an agreement
  • Learn what things to negotiate before signing an agreement

No CME is offered for this webinar.

This activity is FREE for ASE members and nonmembers. Remember to log in to the Member Portal.

 

Assessment of Diastolic Function in Pediatric and Congenital Heart Disease

November 17, 2022 | 8:00 – 9:30 PM ET

This webinar will consist of two didactic lectures followed by debate on assessment of diastolic function in pediatric population. The webinar will highlight the need for accurate assessment of diastolic dysfunction in patients with congenital heart disease as well as children with acquired heart disease while acknowledging the lack of validation in children of parameters used in assessment of diastolic dysfunction in pediatrics.

Speakers

  • Mihn Nguyen, MD, Assistant Professor, Texas Children’s Hospital, Baylor College of Medicine
  • Keri Shafer, MD, Department of Cardiology, Boston Children’s Hospital & Assistant Professor of Pediatrics, Harvard Medical School
  • Andreea Dragulescu, MD, Professor of Pediatrics, The Hospital for Sick Children, University of Toronto
  • Piers Barker, MD, FASE, Professor of Pediatrics and Obstetrics and Gynecology, Duke University Medical Center

Learning Objectives

  • Understand the measures routinely used to assess diastolic dysfunction.
  • Understand the comprehensive assessment of diastolic dysfunction in adult congenital heart disease.
  • Recognize the limitations to assessment of diastolic dysfunction in pediatric population.

Earn 1.5 AMA PRA Category 1 Credit™ (CME/MOC) (pending approval).

This activity is FREE for ASE members and nonmembers. Remember to log in to the Member Portal.

Available Now! echoCORE

ASE released its newest online educational tool echoCORE! The new echocardiography review and evaluation tool helps practitioners of echocardiography review a broad array of topics, key concepts, formulas, and the latest echo advancements in an interactive multiple-choice question and answer format. Special introductory pricing for a one-year subscription is $250 for ASE members and $300 for nonmembers.

Some key product highlights:

  • Developed by 24 experts in the field.
  • Over 38 topics covered.
  • 150 questions
  • Customized feedback with external resource links to ASE guidelines, full lectures on topics, JASE articles, and more.
  • User receives a performance summary on each topic.

Learn more and purchase this product at ASEcho.org/echoCORE. Questions regarding the content? Contact Products@ASEcho.org.

Please note, this activity does not offer CME/MOC at this time.

SIGN UP: Free ASE Webinar on Oct. 27, 5-6 PM ET

Enroll in the first webinar offered by the ASE Veterinary Specialty Interest Group! This free webinar titled Human Deep Hypothermic Cooling versus Animal Hibernation: Echocardiographic Insights, will take place on October 27, 5:00 – 6:00 PM ET, and will explore the cardiovascular changes that occur during deep anesthesia in people and how these changes may be mirrored in animals that hibernate.

Attendees can earn 1 AMA PRA Category 1 Credits (pending approval). In addition to offering 1.0 CME credit, this activity has been developed and registered with ACCME to provide MOC, MOC Part 2, and MOCA 2.0 points in alignment with AMA PRA Category 1 Credit™.

The October CASE is Spookily Good!

The latest issue of CASE, ASE’s open access case reports journal, is available and packed with educational material to share with trainees and colleagues. CASE Editor-in-Chief Dr. Vince Sorrell commented, “It seems like every issue of CASE includes at least one report you need to keep handy as an image-reference in your echo reading room. This issue includes a CASE series demonstrating the normal and pathologic variations of caval and coronary sinus venous anomalies. This is an important report that includes outstanding 3D-CCT image correlations.”

This issue also includes another Congenital Heart Disease article (authored by a sonographer), two cases highlighting the value of Multimodality Imaging, two Hemodynamic Corner cases, and two reports on Cardiac Tumors & Pseudotumors. Dr. Sorrell noted, “Most of us have seen patients with severe mitral annular calcification with or without associated echo-free spaces commonly referred to as liquefaction or caseous necrosis. Some of us have also seen the rare pathologic transformation to fistula formation. Fujiwara and coauthors provide us with an excellent surgically correlated case series of these patients with an absolutely striking video taken in the OR that you simply must see to believe!” Dr. Sorrell’s editorial, “Interpreting the Interpretation,” challenges clinical echocardiographers to continually improve their communication of echo findings to non-specialist colleagues to help improve outcomes.

REMINDER: There are still fee waivers available for sonographer lead authors, sponsored by the Sonography Council, waiting to be claimed by you. Submit your case today! Email Debbie Meyer, Director of Publications (JASE, CASE), or Andie Piddington, Deputy Managing Editor (JASE, CASE), with any questions or to request a case-writing mentorship from an ASE sonographer.

ASE Foundation WASE Study Results Highlighted in News Release by Ultromics

ASE is pleased to share the following news release, provided by Ultromics, highlighting the recently published research initiatives funded through the ASE Foundation, with support from the University of Chicago and MedStar Health, and in-kind support from Ultromics. 

Ultromics’ AI technology analyzes echocardiogram images and predicts cardiac-related mortality better than human analysis.

OXFORD, England, 10th October, 2022

A new study from the World Alliance Societies of Echocardiography (WASE), a major international research initiative led by the American Society of Echocardiography (ASE), says artificial intelligence (AI) is superior to human experts when it comes to predicting cardiac-related death1, a capability that could revolutionize cardiovascular care.

The AI platform, EchoGo by Ultromics, is FDA-cleared, CE Marked and in-use by a growing number of provider organizations across the US and UK. Ultromics is moving quickly and innovatively to help develop novel approaches to improve heart failure detection. The company recently announced a partnership with The Foundation for the National Institutes of Health (FNIH)2 that will use their upcoming FDA breakthrough designated product to improve heart failure detection3, looking specifically at heart failure with preserved ejection (HFpEF).

This latest research from WASE builds on previous work which showed that AI–based analysis could accurately detect outcomes from echocardiographic images1, including combining myocardial strain biomarkers to improve predictive accuracy, recommended as clinical best practice4. With this, an interest in the AI’s ability to make outcome predictions was compared with conventional analysis by human experts.

Dr. Federico M. Asch, lead study author and Director of the Cardiovascular and Echo Core Labs at MedStar Health Research Institute, said: “AI derived results outperformed traditional manual analysis in the generation of Left Ventricular Ejection Fraction and Global Longitudinal Strain, as the AI proved to be a significant predictor of outcomes, which traditional reads by expert echocardiographers could not achieve.”

The study looked at 870 patients admitted to 13 hospitals in 9 countries (Asia, Europe, United States, Latin America), who had acute COVID-19 and underwent transthoracic echocardiography.

The research was supported in partnership by MedStar Health, University of Chicago, and Ultromics. Dr. Federico Asch, Director of the Cardiovascular and Echo Core Labs at MedStar Health Research Institute, and Dr. Roberto Lang, Director of the University of Chicago’s Non-invasive Cardiac Imaging Laboratory, served as principal investigators.

Echocardiographic left ventricular ejection fraction (LVEF) and left ventricular longitudinal strain (LVLS) were obtained manually by multiple expert readers and by the automated EchoGo AI platform from Ultromics. The ability of the manual and AI analyses to predict all-cause mortality was compared.

AI-derived LVEF and LVLS were predictors of mortality in univariable and multivariable regression analysis (odds ratio, 0.974 [95% CI, 0.956-0.991; P = .003] for LVEF; odds ratio, 1.060 [95% CI, 1.019-1.105; P = .004] for LVLS), but LVEF and LVLS obtained by manual analysis were not1.

Direct comparison of the predictive value of AI versus manual measurements of LVEF and LVLS showed that AI was significantly better (P = .005 and P = .003, respectively)1. In addition, AI-derived LVEF and LVLS had more significant and stronger correlations to other objective biomarkers of acute disease than manual reads. Lastly, , inter-operator agreement for LVEF and GLS was 23% and 44% (respectively) lower for manual measurements than that achieved by the AI1.

Dr Ross Upton, CEO and Founder of Ultromics, said “Developing precision strategies for cardiovascular disease is more critical than ever, particularly heart failure, where patient cases and costs are expected to double between now and 20305. We built our AI platform to improve the accuracy of heart failure detection and prevent worsening cardiac outcomes.” Upton continued: “The technology was built using deep learning, from 10 years’ worth of echocardiographic images tied to outcomes, to provide precision analysis independent of expert clinicians”.

This study demonstrates the prognostic value of AI for routine primary care and improved accuracy for prediction of cardiovascular disease. Ultromics will continue to explore how AI can contribute to the development of echocardiography and preventative care.

Click here to read the published paper in The Journal of the American Society of Echocardiography (JASE).

Dr. Asch will join Gary Woodward, pHD, Ultromics Chief Technology Officer,  on a webinar on November 3rd, 2022 to discuss these ground-breaking results. Visit www.ultromics.com to register for the online seminar.

About Ultromics:

Ultromics is the leader in artificial intelligence for echocardiography enabling earlier detection and risk stratification of heart failure for better outcomes, lower costs, and improved patient care. All providers, regardless of their care setting, can now make precise, accurate, and timely diagnoses of heart failure with Ultromics’ AI technology. The cloud-based platform, EchoGo, offers a simple, secure and seamless way to augment your existing technology and workflow with fully automated, advanced echo analysis including critical advanced measures recommended by guidelines.. The technology is FDA-cleared and trusted by world-renowned organizations such as Mayo Clinic and the NHS England. Learn more: https://www.ultromics.com

For media inquiries:

Ultromics VP of Marketing – Jeff.Zinger@ultromics.com

  1. Asch J, et al, J Am Soc Echocardiogr. 2022;35:1-55
  2. https://www.ultromics.com/press-releases/ultromics-joins-fnih-partnership-to-transform-heart-failure-detection
  3. EchoGo Heart Failure is pending FDA 510k clearance
  4. https://www.onlinejase.com/article/S0894-7317(21)00483-1/fulltext
  5. Smiseth, OA, et al. European Heart Journal. 2015;37:1196–1207
  6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494150/

Medical Ultrasound Awareness Month!

October is Medical Ultrasound Awareness Month (MUAM)!

During MUAM and in the coming months, ASE will share #ILookLikeASonographer social media posts to celebrate our sonographer members and increase awareness about this important and rewarding profession.

Additionally, and ASEF will shine a spotlight on ultrasound professionals all month long. Submit a photo of a sonographer you with with along with an appreciation message to Mary Carmody. Submissions will be shared on ASEF’s website.

Learn how you can get involved!

Winners of the 2023 Image Calendar Competition

Thank you to everyone who uploaded echo images and voted on Connect@ASE during the Image Calendar Competition. Please join ASE in congratulating the following members, whose images have been selected for the 2023 ASE Image Calendar:

  • Melynda Ancell, RDCS (AE, PE)
  • Bonita Anderson, DMU, (Cardiac), MAppSc (MedU/S), ACS, FASE
  • Clara Angulo, ACS, MBA, FASE
  • Gerald Jason Ballo, RN, RDCS, RCS, BSE
  • Luciano Belem, MD
  • Kana Fujikura, MD, PhD, FASE
  • John Goodman, RDCS, RVT
  • Jason Pereira, MS, RCS, FASE
  • Marie Sadler, RDCS
  • Madeline Schiminger, MPH, RDCS (AE, PE), FASE
  • Nicole Simpkins, BS, RDCS (AE, PE), RCCS, FASE
  • Angelica Valentin, RCS
  • Megan Yamat, ACS, FASE
  • Kathryn Ziegler, BS, RDCS, FASE

To receive your copy of the 2023 Image Calendar, renew your ASE membership by December 31, 2022!

ASE 2023 Abstract Submissions Now Open!

Submit your abstract of original research or clinical cases to be considered for presentation at the premier cardiovascular ultrasound conference of the year, the 34th Annual ASE Scientific Sessions in National Harbor, Maryland, June 23-26, 2023

Begin your submission online today! Presenters benefit from dedicated viewing times, a global audience that promotes future collaborative work, eligibility for travel support, publication in JASE, and discounted conference registration rates. Visit the ASE 2023 Call for Science for more information. Submission closes Wednesday, February 8, 2023, 11:59 ET

October JASE – More Lessons from SARS-CoV-2

The October JASE includes, “Simplified Lung Ultrasound Examination and Telehealth Feasibility in Early SARS-CoV-2 Infection,” from Drs. Kimura, Resnikoff, Tran, Bonagiri, and Spierling Bagsic.

Dr. Kimura noted, “Although the nature of SARS-CoV-2 infection seems to be constantly changing, we found that the use of a quick-and-easy ultrasound exam can help identify outpatients with early lung involvement and a worse prognosis, even before detection by skin temperature or pulse oximetry. The simplicity of the exam enabled patients to image themselves from isolation and suggests the feasibility of imaging from home, a school, a pharmacy, or even a drive-through testing site. The COVID-19 pandemic taught us a new pathway to apply ultrasound which may involve a combination of simplified self-imaging, telehealth, and artificial intelligence, that will improve healthcare delivery from within the community on a variety of diseases in the future.”

Another COVID-19 study looks at serial left and right ventricular strain analysis in patients who have recovered from the infection. Additional clinical investigations also look at 3D echocardiography, incremental value of global longitudinal strain to stress echocardiography in outcome assessment, several topics related to tricuspid and mitral regurgitation, left atrial function and outcomes in cryptogenic stroke, transcatheter aortic valve replacement in children, and enhancing quality in pediatric echocardiography.

Two brief research communications round out the issue. The President’s Message from Stephen H. Little, MD, FASE, shares the multi-faceted ways that ASE is a global organization, and why this incredible diversity is so important to the future of advancing cardiovascular ultrasound. The continuing education and meeting calendar outlines a multitude of learning options near and far.

The October 19 deadline to submit papers to be considered for the JASE Echocardiography in Valvular Heart Disease focus issue (published in early 2023) is almost here. Questions? Contact JASE managing editor, Debbie Meyer, at dmeyer@asecho.org

Nominations for ASE Positions are Now Open

ASE is seeking the best and brightest members to move forward the mission and goals of the Society and the ASE Foundation. Now is your opportunity to become a leader in ASE! The deadline for submission of nominations is November 30, 2022. Ask an active ASE member TODAY to submit your nomination. Please contact Nominations@ASEcho.org with any questions or to submit nominations.

LEARN MORE!